Anita Finnegan, Nova Leah

Nova Leah Receives Certification for ISO 27001 and ISO 9001

By MedTech Intelligence Staff
No Comments
Anita Finnegan, Nova Leah

The certifications recognize the company’s commitment to information security management and quality management systems.

This week Michelle Jump of Nova Leah will be presenting at the MedTech Intelligence conference, Medical Device Cybersecurity: Legacy Device Remediation, Compensating Controls & End-of-Life | September 26–27, 2019 | Cambridge, MAToday Nova Leah announced that it received certifications for ISO 9001 and ISO 27001 from the National Standards Authority Ireland. ISO 27001 is an international standard for information security management that outlines best practice for implementing legal, physical and technical controls that enable confidentiality, integrity and availability of information assets. ISO 9001 recognizes a commitment to quality management systems, as its structure provides for communication and understanding of processes involved for producing consistent and high-quality products and services for a customer. Nova Leah provides cybersecurity solutions to medtech manufacturers.

Anita Finnegan, Nova Leah
Nova Leah, CEO and founder Anita Finnegan, Ph.D.

“Our customers work to very high standards in terms of quality and information security. As a provider of expert cybersecurity risk management solutions, we felt it absolutely necessary that we provide our customers with assurance of our value, appreciation and dedication to high quality standards in terms of products and services,” said company CEO and founder Anita Finnegan, Ph.D. in a press release.

SelectEvidence, Nova Leah’s flagship product, is a cybersecurity risk assessment platform that helps medical device manufacturers identify threats to products and guides them through implementing security controls to mitigate the threats.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *